Across TCGA pan-cancer cohorts, LINC01951 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC01951 data layer compared with 8 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher LINC01951 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01951 expression acts as an unfavorable survival marker.

CESC are the cancer types where LINC01951 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	All	0.176	0.740	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: LINC01951 tumor-vs-normal RNA expression · all LINC01951 data types